Gilead Sciences (GILD) Current Deferred Tax Assets (2009 - 2016)
Gilead Sciences (GILD) reported Current Deferred Tax Assets of $857 million for Q4 2016, up 3.5% from $828 million a year earlier and up 12.5% from the prior quarter.
Powered by 
Analysis
Gilead Sciences (GILD) Current Deferred Tax Assets (2009 - 2016) Analysis & Trends
Dating back to Q2 2009, Gilead Sciences' Current Deferred Tax Assets record includes 30 quarters.
- Current Deferred Tax Assets has increased for five consecutive years, with a five-year compound annual growth rate of 32.7% (FY2011 to FY2016).
- By year, Current Deferred Tax Assets came in at $828 million in FY2015 (+63.0%), $508 million in FY2014 (+53.5%), $331 million in FY2013 (+26.0%) and $262.64 million in FY2012 (+26.2%).
- The Q4 2016 figure ranks as the highest quarterly Current Deferred Tax Assets since Q3 2015.
- Year over year, Current Deferred Tax Assets gained in seven of the last eight quarters, with growth averaging 51.8%.
- The high point for year-over-year Current Deferred Tax Assets in five years was Q3 2015 (growth of 132.5%); the low point was Q1 2012 (a decline of 30.2%).
- Per Business Quant data, the three quarters before Q4 2016 came in at $762 million (Q3 2016), $835 million (Q2 2016) and $830 million (Q1 2016).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Bristol Myers Squibb | 127.55 Bn | 78.82 Bn | 9.25 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2016 | 857.00 Mn |
| Sep 30, 2016 | 762.00 Mn |
| Jun 30, 2016 | 835.00 Mn |
| Mar 31, 2016 | 830.00 Mn |
| Dec 31, 2015 | 828.00 Mn |
| Sep 30, 2015 | 894.00 Mn |
| Jun 30, 2015 | 833.00 Mn |
| Mar 31, 2015 | 655.00 Mn |
| Dec 31, 2014 | 508.00 Mn |
| Sep 30, 2014 | 384.59 Mn |
| Jun 30, 2014 | 386.58 Mn |
| Mar 31, 2014 | 348.94 Mn |
| Dec 31, 2013 | 331.00 Mn |
| Sep 30, 2013 | 239.29 Mn |
| Jun 30, 2013 | 224.43 Mn |
| Mar 31, 2013 | 211.94 Mn |
| Dec 31, 2012 | 262.64 Mn |
| Sep 30, 2012 | 222.57 Mn |
| Jun 30, 2012 | 213.45 Mn |
| Mar 31, 2012 | 193.94 Mn |
API Access
Gilead Sciences Current Deferred Tax Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-tax-assets&ticker=GILD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-tax-assets", "ticker": "GILD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-tax-assets&ticker=GILD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();